Edition:
United States

Cambrex Corp (CBM.N)

CBM.N on New York Stock Exchange

51.40USD
18 Aug 2017
Change (% chg)

$-0.60 (-1.15%)
Prev Close
$52.00
Open
$51.55
Day's High
$51.88
Day's Low
$51.30
Volume
68,307
Avg. Vol
68,025
52-wk High
$62.50
52-wk Low
$38.35

CBM.N

Chart for CBM.N

About

Cambrex Corporation (Cambrex) is a life sciences company. It provides products and services for the development and commercialization of generic therapeutics. It operates through four segments, which are manufacturing facilities that have been aggregated as a single segment. Its manufacturing facilities are owned by the... (more)

Overall

Beta: 2.29
Market Cap(Mil.): $1,682.30
Shares Outstanding(Mil.): 32.73
Dividend: --
Yield (%): --

Financials

  CBM.N Industry Sector
P/E (TTM): 17.45 31.45 32.56
EPS (TTM): 2.95 -- --
ROI: 18.81 15.33 14.89
ROE: 23.78 16.35 16.13

BRIEF-Cambrex Corp invests $24 mln in a new facility

* ‍To invest $24 million in a new facility to manufacture highly potent APIs at its Charles City, Iowa plant​ Source text for Eikon: Further company coverage:

Aug 08 2017

BRIEF-Cambrex Corp Q2 revenue $134.6 million

* Q2 adjusted earnings per share $0.76 from continuing operations

Aug 04 2017

Earnings vs. Estimates